BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23721227)

  • 1. Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011.
    Kelly-Mancuso G; Kopelan B; Azizkhan RG; Lucky AW
    Pediatr Dermatol; 2014; 31(2):159-62. PubMed ID: 23721227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa.
    Kho YC; Rhodes LM; Robertson SJ; Su J; Varigos G; Robertson I; Hogan P; Orchard D; Murrell DF
    Arch Dermatol; 2010 Jun; 146(6):635-40. PubMed ID: 20566927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause-specific risks of childhood death in inherited epidermolysis bullosa.
    Fine JD; Johnson LB; Weiner M; Suchindran C
    J Pediatr; 2008 Feb; 152(2):276-80. PubMed ID: 18206702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermolysis bullosa in Northern Ireland.
    McKenna KE; Walsh MY; Bingham EA
    Br J Dermatol; 1992 Oct; 127(4):318-21. PubMed ID: 1419751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database.
    Petrof G; Papanikolaou M; Martinez AE; Mellerio JE; McGrath JA; Bardhan A; Harper N; Heagerty A; Ogboli M; Chiswell C; Moss C
    Br J Dermatol; 2022 May; 186(5):843-848. PubMed ID: 34927719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and etiology of childhood epidermolysis bullosa mortality.
    Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK
    J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of epidermolysis bullosa in Scotland.
    Horn HM; Priestley GC; Eady RA; Tidman MJ
    Br J Dermatol; 1997 Apr; 136(4):560-4. PubMed ID: 9155958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa.
    Yuen WY; Duipmans JC; Molenbuur B; Herpertz I; Mandema JM; Jonkman MF
    Br J Dermatol; 2012 Aug; 167(2):374-82. PubMed ID: 22512697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C;
    Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Junctional epidermolysis bullosa non-Herlitz with urethral affection].
    Zappel K; Bruckner-Tuderman L; Müller D; Audring H; Kolde G; Biewald W; Blume-Peytavi U
    J Dtsch Dermatol Ges; 2003 Jan; 1(1):50-6. PubMed ID: 16285293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermolysis bullosa: pathophysiology and nursing care.
    Gannon BA
    Neonatal Netw; 2004; 23(6):25-32. PubMed ID: 15612418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal junctional epidermolysis bullosa: treatment conundrums and ethical decision making.
    Yang CS; Kroshinksy D; Cummings BM
    Am J Clin Dermatol; 2014 Oct; 15(5):445-50. PubMed ID: 25117154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa.
    Yan EG; Paris JJ; Ahluwalia J; Lane AT; Bruckner AL
    J Perinatol; 2007 May; 27(5):307-11. PubMed ID: 17363907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herlitz junctional epidermolysis bullosa.
    Laimer M; Lanschuetzer CM; Diem A; Bauer JW
    Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of novel LAMA3 mutation in Herlitz junctional epidermolysis bullosa in a Jordanian family.
    Badran EF; Battah HA; Akl KF; Khalil RW; Al Amori I
    Australas J Dermatol; 2013 Aug; 54(3):218-21. PubMed ID: 22963541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand.
    Gear R; Poke G; Neas K; Finnigan J; Cassidy S; Forsyth D; Blishen M; Purvis D
    Australas J Dermatol; 2022 Feb; 63(1):62-67. PubMed ID: 34905622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the estimation of prevalence of epidermolysis bullosa in Japan].
    Inaba Y; Kitamura K; Ogawa H; Manabe M; Sasai Y
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):1021-6. PubMed ID: 2601109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper airway complications of junctional epidermolysis bullosa.
    Ida JB; Livshitz I; Azizkhan RG; Lucky AW; Elluru RG
    J Pediatr; 2012 Apr; 160(4):657-661.e1. PubMed ID: 22050875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.